Rare spinal tumor review describes surgical relief alongside complications
Published surgical cases commonly reported symptom relief, while the small evidence base and unspecified follow-up limit conclusions about long-term outcomes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Surgical reports of this rare spinal tumor often described complete removal and symptom relief, but complications, including a death, also occurred. These findings summarize outcomes after surgery in published patients. They do not show how surgery compares with observation or other treatments, and the abstract does not establish how long improvements or freedom from recurrence lasted.
The abstract does not describe a nonsurgical comparison group or the duration of follow-up. Published outcomes in this rare condition cannot establish an individual patient's chance of benefit or harm.
What researchers found
Complete symptom resolution
After surgery in the reviewed patients; no comparison group or follow-up duration is reported in the abstract.
What the review covered
Researchers examined surgery for intradural extramedullary hemangioblastomas, an uncommon type of benign spinal tumor. They also described a patient with a neck-region lesion who had no symptoms after removal and no recurrence on follow-up imaging.
What remains uncertain
The additional case illustrates a favorable outcome, but it does not establish how often that outcome occurs. The review's reported complication rate also included a death, so symptom improvement should be read alongside the potential harms.
The original publication
Navigating the Unseen: A Rare Case of Intradural Extramedullary Spinal Hemangioblastoma and a Systematic Review of Surgical Challenges and Outcomes.
Esmaeilzadeh M, Shirani M, Rezaee H et al.
World Neurosurg · 2026
- PubMed ID
- 41539597
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.